| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/25/1997 | US5614610 Tumor immunotherapy using anti-idiotypic antibodies |
| 03/25/1997 | US5614500 Compositions containing highly purified factor IX proteins prepared by immunoaffinity chromatography |
| 03/25/1997 | US5614488 Cytoxic fragment of a peptide toxin |
| 03/25/1997 | US5614409 Production of IBDV VP2 in highly immunogenic form |
| 03/25/1997 | US5614404 Plasmid vector for insertion of human immunodeficiency virus dna sequences into a pox virus |
| 03/25/1997 | US5614384 Hepatitis B virus surface proteins with reduced host carbohydrate content |
| 03/25/1997 | US5614366 HTLV-I peptide antigens and kit |
| 03/25/1997 | US5614195 Coccidiosis poultry vaccine |
| 03/25/1997 | US5614194 Protective peptide antigen |
| 03/25/1997 | US5614193 Hantavirus vaccine |
| 03/25/1997 | US5614192 T cell receptor peptides as therapeutics for immune-related disease |
| 03/25/1997 | US5614191 Antitumor |
| 03/25/1997 | US5614187 Conferring tolerance to foreign tissue in recipient mammal |
| 03/25/1997 | CA2067178C Solid tumor treatment method and composition |
| 03/25/1997 | CA2050479C Cd3 specific recombinant antibody |
| 03/25/1997 | CA1339027C Synthetic peptides, antibodies directed against them, and the use thereof |
| 03/25/1997 | CA1339014C Antibodies to a4 amyloid peptide |
| 03/25/1997 | CA1339013C Cross-protective human monoclonal antibody compositions |
| 03/23/1997 | CA2185617A1 Method for recovering immunoglobulin from fractions produced during fractionation of human blood plasma |
| 03/20/1997 | WO1997010351A1 Exopolysaccharides of burkholderia pseudomallei and burkholderia mallei |
| 03/20/1997 | WO1997010347A1 Expression cassettes and methods for delivery of animal vaccines |
| 03/20/1997 | WO1997010269A1 Immunotherapeutic methods using tumor antigenic peptides coated on cells and vaccines made thereof |
| 03/20/1997 | WO1997010249A1 Toxoplasma gondii glycoconjugates |
| 03/20/1997 | WO1997010002A1 Immunotherapy of cancer and infectious disease using antigen-presenting cells sensitized with heat shock protein-antigen complexes |
| 03/20/1997 | WO1997010001A1 Treatment or prevention of neoplastic and infectious diseases with heat shock/stress proteins |
| 03/20/1997 | WO1997010000A1 Therapeutic and prophylactic methods using heat shock proteins |
| 03/20/1997 | WO1997009999A1 Methods and compositions for treatment of hsv-2 infections and conditions |
| 03/20/1997 | WO1997009994A1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 03/20/1997 | WO1997003187A3 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 03/20/1997 | DE19534579A1 Nucleinsäure-Moleküle codierend Proteine, die die Adhäsion von Neisseria-Zellen an humane Zellen vermitteln Nucleic acid molecules encoding proteins which mediate the adhesion of Neisseria cells to human cells |
| 03/20/1997 | CA2232048A1 Treatment or prevention of neoplastic and infectious diseases with heat shock/stress proteins |
| 03/20/1997 | CA2232033A1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 03/20/1997 | CA2232023A1 Expression cassettes and methods for delivery of animal vaccines |
| 03/20/1997 | CA2232012A1 Toxoplasma gondii glycoconjugates |
| 03/20/1997 | CA2232002A1 Immunotherapy of cancer and infectious disease using antigen-presenting cells sensitized with heat shock protein-antigen complexes |
| 03/20/1997 | CA2231998A1 Therapeutic and prophylactic methods using heat shock proteins |
| 03/19/1997 | EP0763543A2 A method for preparing an inflammatory cytokine (MIP-2) and diagnostic and therapeutic applications for the cytokine or its antibody |
| 03/19/1997 | EP0763361A2 Mycobacterium vaccae for treatment of long term autoimmune conditions |
| 03/19/1997 | EP0763114A2 Hepatitis g virus and molecular cloning thereof |
| 03/19/1997 | EP0763104A1 Human dna topoisomerase i-alpha |
| 03/19/1997 | EP0763059A1 Recombinant allergen, fragments thereof, corresponding recombinant dna molecules, vectors and hosts containing the dna molecules, diagnostic and therapeutic uses of said allergens and fragments |
| 03/19/1997 | EP0763046A1 Dna encoding gls1 |
| 03/19/1997 | EP0763045A1 Haemopoietic maturation factor |
| 03/19/1997 | EP0762895A1 Synthetic vaccine for protection against human immunodeficiency virus infection |
| 03/19/1997 | EP0762894A1 Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen |
| 03/19/1997 | EP0762892A1 Diphtheria toxin vaccines bearing a mutated r domain |
| 03/19/1997 | EP0762891A1 Immunogenic pharmaceuticals |
| 03/19/1997 | EP0762885A1 Glial mitogenic factors, their preparation and use |
| 03/19/1997 | EP0762884A1 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof |
| 03/19/1997 | EP0762881A1 Method and reagents for the treatment of rheumatoid arthritis |
| 03/19/1997 | EP0762876A1 A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof |
| 03/19/1997 | EP0762875A1 Microparticle delivery system |
| 03/19/1997 | EP0762870A1 Virosome-mediated intracellular delivery of therapeutic agents |
| 03/19/1997 | EP0626861B1 Treatment for asthma |
| 03/19/1997 | EP0445135B1 Immogenically active fractions of borrelia burgdorferi |
| 03/19/1997 | CN1145641A DNA mutagenesis by random fragmentation and reassembly |
| 03/19/1997 | CN1145636A Vascular endothelial growth factor 2 |
| 03/19/1997 | CN1145254A Prevention of hydrophobia by co-use of alpha type gene reorganizing interfrence agent and hydrophobia vaccine |
| 03/19/1997 | CN1145223A Endothelin receptor antagonists |
| 03/19/1997 | CN1145168A In ovo vaccination against coccidiosis |
| 03/19/1997 | CN1145167A In ovo vaccination against coccidiosis |
| 03/19/1997 | CA2182541A1 Novel, ubiquitous potassium-channel proteins and genes for the same |
| 03/18/1997 | US5612487 Viricides, antigens and tobacco plants |
| 03/18/1997 | US5612453 Viricides |
| 03/18/1997 | US5612332 Inhibiting protein glycosylation |
| 03/18/1997 | US5612216 Nucleotide sequence encoding intercellular adhesion molecule-1 and fragments thereof |
| 03/18/1997 | US5612201 Genetic engineering and kits for determination of gene expression |
| 03/18/1997 | US5612195 Recombinant production of a human interferon (IFN)-gamma antagonist cytokine |
| 03/18/1997 | US5612042 Vaccine against streptococcus suis infection |
| 03/18/1997 | US5612041 Recombinant herpes simplex gD vaccine |
| 03/18/1997 | US5612040 Non-infectious foot-and-mouth disease viruses |
| 03/18/1997 | US5612037 Influenza virus subunit conjugates |
| 03/18/1997 | US5612036 Crosslinked polypeptide vaccine with cysteine groups and carriers |
| 03/18/1997 | US5612035 Immunology |
| 03/18/1997 | US5612034 Super-globuling for in vivo extended lifetimes |
| 03/18/1997 | US5612033 Methods of treatment using heat-treated IGM antibody preparations |
| 03/18/1997 | US5612032 Method for diagnosing tumors using mouse monoclonal antibodies |
| 03/18/1997 | US5612030 Anti-idiotype monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma |
| 03/18/1997 | CA2031528C Radionuclide metal chelates for the radiolabeling of proteins |
| 03/13/1997 | WO1997009437A1 Materials and methods relating to the attachment and display of substances on cell surfaces |
| 03/13/1997 | WO1997009433A1 Cell-cycle checkpoint genes |
| 03/13/1997 | WO1997009429A2 Compounds and methods for diagnosis of tuberculosis |
| 03/13/1997 | WO1997009428A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 03/13/1997 | WO1997009418A1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor |
| 03/13/1997 | WO1997009351A1 Recombinant anti-cd4 antibodies for human therapy |
| 03/13/1997 | WO1997009068A2 Interactive molecular conjugates |
| 03/13/1997 | WO1997009064A1 Use of muteins of wild-type cytokines as immunogens |
| 03/13/1997 | WO1997009051A1 Analogs for specific oligosaccharide-neuregulin interactions and uses thereof |
| 03/13/1997 | WO1997008955A1 Bacterial delivery system |
| 03/13/1997 | WO1996034964A3 Stable variant hk2 polypeptide |
| 03/13/1997 | CA2684425A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 03/13/1997 | CA2653566A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 03/13/1997 | CA2231372A1 Materials and methods relating to the attachment and display of substances on cell surfaces |
| 03/13/1997 | CA2231190A1 Cell-cycle checkpoint genes |
| 03/13/1997 | CA2231182A1 Recombinant anti-cd4 antibodies for human therapy |
| 03/13/1997 | CA2230927A1 Compounds and methods for diagnosis of tuberculosis |
| 03/13/1997 | CA2230858A1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor |
| 03/13/1997 | CA2230557A1 Interactive molecular conjugates |
| 03/13/1997 | CA2230385A1 Analogs for specific oliogosaccharide-neuregulin interactions and uses thereof |
| 03/12/1997 | EP0761819A1 Exopolysaccharides of burkholderia pseudomallei and burkholderia mallei |